Strumento inattivo

Azioni Gelesis Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Gelesis Expands Ongoing Weight Loss Study to Serve as U.S. Pivotal Trial, Significantly Accelerating Development Timeline	27/07/15
Gelesis Presents Additional Data at European Congress on Obesity	22/05/15

Dirigenti	Titolo	Età	Da
David Pass COO	Chief Operating Officer	56	01/09/16
Angelo Tremblay PRN	Corporate Officer/Principal	-	-
Cosimo Saponaro PRN	Corporate Officer/Principal	-	-

Amministratori	Titolo	Età	Da
Clayton Christopher BRD	Director/Board Member	51	-
Kathryn Cavanaugh BRD	Director/Board Member	50	01/01/22
Alison Bauerlein BRD	Director/Board Member	42	05/01/22

Settore

	Variaz. 1 gen.	Capi.
SAMSUNG BIOLOGICS CO.,LTD.	+1,45%	40,51 Mrd
BIOGEN INC.	-15,94%	31,67 Mrd
UCB	+52,66%	24,62 Mrd
BIOMARIN PHARMACEUTICAL INC.	-14,50%	15,65 Mrd
INCYTE CORPORATION	-14,38%	12,07 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,12%	11,97 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42,56%	11,61 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+4,87%	8,81 Mrd
INNOVENT BIOLOGICS, INC.	-4,33%	8,5 Mrd